BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26936386)

  • 1. The role of cofilin-l in vulvar squamous cell carcinoma: A marker of carcinogenesis, progression and targeted therapy.
    Wu Q; Jiang Y; Cui S; Wang Y; Wu X
    Oncol Rep; 2016 May; 35(5):2743-54. PubMed ID: 26936386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of RhoA in vulvar squamous cell carcinoma: a carcinogenesis, progression, and target therapy marker.
    Wang J; Wu Q; Zhang LH; Zhao YX; Wu X
    Tumour Biol; 2016 Mar; 37(3):2879-90. PubMed ID: 26409448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
    Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
    Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside IV inhibits cell proliferation in vulvar squamous cell carcinoma through the TGF-β/Smad signaling pathway.
    Zhao Y; Wang L; Wang Y; Dong S; Yang S; Guan Y; Wu X
    Dermatol Ther; 2019 Jul; 32(4):e12802. PubMed ID: 30536730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
    Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
    Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased osteopontin expression is associated with progression from vulvar precancerous lesions to vulvar squamous cell carcinoma.
    Wu Z; Shen Y; Gong K; Wu Z; Zhang T; Zhang X; Li S
    Arch Gynecol Obstet; 2014 Mar; 289(3):637-44. PubMed ID: 23978873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA expression profile of vulvar squamous cell carcinoma and identification of the oncogenic role of miR-590-5p.
    Yang X; Wu X
    Oncol Rep; 2016 Jan; 35(1):398-408. PubMed ID: 26498065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitro.
    Wang Z; Førsund MS; Trope CG; Nesland JM; Holm R; Slipicevic A
    Cancer Med; 2018 Aug; 7(8):3955-3964. PubMed ID: 29963769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA‑4712‑5p promotes proliferation of the vulvar squamous cell carcinoma cell line A431 by targeting PTEN through the AKT/cyclin D1 signaling pathways.
    Yang S; Zhao Y; Wang L; Liu C; Lu Y; Fang Z; Shi H; Zhang W; Wu X
    Oncol Rep; 2019 Nov; 42(5):1689-1698. PubMed ID: 31545465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients.
    Magnussen GI; Hellesylt E; Nesland JM; Trope CG; Flørenes VA; Holm R
    BMC Cancer; 2013 Jun; 13():288. PubMed ID: 23767999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALDI Mass Spectrometry Imaging Reveals Decreased CK5 Levels in Vulvar Squamous Cell Carcinomas Compared to the Precursor Lesion Differentiated Vulvar Intraepithelial Neoplasia.
    Zhang C; Arentz G; Winderbaum L; Lokman NA; Klingler-Hoffmann M; Mittal P; Carter C; Oehler MK; Hoffmann P
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR‑3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression.
    Yang XH; Guo F
    Mol Med Rep; 2018 May; 17(5):6397-6404. PubMed ID: 29512734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Retinoic Acid Receptor β Gene With Onset and Progression of Lichen Sclerosus-Associated Vulvar Squamous Cell Carcinoma.
    Rotondo JC; Borghi A; Selvatici R; Mazzoni E; Bononi I; Corazza M; Kussini J; Montinari E; Gafà R; Tognon M; Martini F
    JAMA Dermatol; 2018 Jul; 154(7):819-823. PubMed ID: 29898214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of CFL1 in gastric cancer and the effects of its silencing by siRNA with a nanoparticle delivery system in the gastric cancer cell line.
    Daryabari SS; Fathi M; Mahdavi M; Moaddab Y; Hosseinpour Feizi MA; Shokoohi B; Safaralizadeh R
    J Cell Physiol; 2020 Oct; 235(10):6660-6672. PubMed ID: 31990066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and clinical significance of E-cadherin and β-catenin in the vulvar squamous cell carcinoma tissues].
    Jia L; Ouyang L; Zhou Y; Song ZX; Tong X; Li B; Zhang ST; He Z
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jun; 48(6):437-41. PubMed ID: 24103123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression.
    de Melo Maia B; Rodrigues IS; Akagi EM; Soares do Amaral N; Ling H; Monroig P; Soares FA; Calin GA; Rocha RM
    Oncotarget; 2016 Aug; 7(31):49217-49231. PubMed ID: 27359057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of sputum cofilin-1 as indicator of malignancy.
    Rangel MP; Antonangelo L; Acencio MMP; Faria CS; de Sá VK; Leão PS; Farhat C; Fabro AT; Longatto Filho A; Reis RM; Takagaki T; Capelozzi VL
    Braz J Med Biol Res; 2018; 51(8):e7138. PubMed ID: 29846436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive evaluation of caspase-14 in vulvar neoplasia: an opportunity for treatment with black raspberry extract.
    Joehlin-Price AS; Elkins CT; Stephens JA; Cohn DE; Knobloch TJ; Weghorst CM; Suarez AA
    Gynecol Oncol; 2014 Dec; 135(3):503-9. PubMed ID: 25256208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CXC chemokine receptor type 4 expression and clinicopathologic features in human vulvar cancer.
    Shiozaki T; Tabata T; Ma N; Yamawaki T; Motohashi T; Kondo E; Tanida K; Okugawa T; Ikeda T
    Int J Gynecol Cancer; 2013 Jul; 23(6):1111-7. PubMed ID: 23765204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.